SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001399529-21-000069
Filing Date
2021-04-12
Accepted
2021-04-12 17:16:27
Documents
14
Period of Report
2021-04-08
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K drna-20210408.htm   iXBRL 8-K 37547
  Complete submission text file 0001399529-21-000069.txt   180205

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT drna-20210408.xsd EX-101.SCH 2433
3 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT drna-20210408_cal.xml EX-101.CAL 720
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT drna-20210408_def.xml EX-101.DEF 1657
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT drna-20210408_lab.xml EX-101.LAB 23970
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT drna-20210408_pre.xml EX-101.PRE 12656
7 EXTRACTED XBRL INSTANCE DOCUMENT drna-20210408_htm.xml XML 10959
Mailing Address 75 HAYDEN AVENUE LEXINGTON MA 02421
Business Address 75 HAYDEN AVENUE LEXINGTON MA 02421 617 621 8097
Dicerna Pharmaceuticals Inc (Filer) CIK: 0001399529 (see all company filings)

IRS No.: 205993609 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36281 | Film No.: 21821413
SIC: 2834 Pharmaceutical Preparations